Please Wait...

The Scoop from SCOPE Summit 2016

SCOPE Summit 2016 was a busy and exciting event for the Bioclinica team! In addition to the great discussions at the Bioclinica booth, Ron Burns, VP, Product Management, Bioclinica eHealth Solutions, held a session entitled, "Integrating Mobile Application Generated Patient Data into Your Risk-Based Monitoring Strategy." This session included Bioclinica eHealth App xChange Partner, AiCure. Together, Bioclinica and AiCure demonstrated how patient-centered mobile applications – from the newest biosensors to the complete digital health records – are broadening the horizons for patient safety and trial quality when the data are integrated into EDC and risk-based monitoring solutions.

Kristin Mauri, Senior Director Global Consulting, Bioclinica eHealth solutions, caught up with Adam Hanina, CEO of AiCure, before the session for a quick video interview and introduction.

AiCure's artificial intelligence (AI) confirms that patients are actually taking their medications correctly. The AI technology includes facial identification, medication ID, and confirmation of ingestion. All this information is transmitted in real time to a central dashboard. By tying this innovative technology to the Compass Risk-Based Monitoring platform, Bioclinica will provide key risk indicators and servicing throughout the life of a clinical trial. This innovation is particularly interesting to sponsors in therapeutic areas concerned with medication adherence.

If you weren't able to catch up with us at the summit Contact us for a one-on-one call.



Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil…
bioclinica (Yesterday)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace…
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c…
bioclinica (2 days ago)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '…
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen